Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiofrequency Ablation for Treating Cardiac Arrhythmias in Brazil: Status in the Unified Health System.

Arquivos brasileiros de cardiologia·2026
Same author

Guideline on Stress Echocardiography - 2026.

Arquivos brasileiros de cardiologia·2026
Same author

Position Statement on Multimodal Cardiac Imaging in Patients with Systemic Diseases - 2026.

Arquivos brasileiros de cardiologia·2026
Same author

Multimodal Artificial Intelligence for Cardiac Amyloidosis Diagnosis: Integrating Echocardiography With Clinical and Laboratory Data for Improved Detection.

Circulation. Cardiovascular imaging·2026
Same author

Original investigation: evolution of long-term cardiac tumours in patients with tuberous sclerosis.

Orphanet journal of rare diseases·2026
Same author

Feasibility of transthoracic echocardiography in the prone position with a low-cost adaptation: morphological, functional, and hemodynamic analysis.

Einstein (Sao Paulo, Brazil)·2026

Related Experiment Video

Updated: May 30, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

"Hyper-response" evaluated by 3D echocardiography after cardiac resynchronization therapy.

Viviane Tiemi Hotta1, Marcelo Luiz Campos Vieira, Daniela do Carmo Rassi

  • 1Instituto do Coração, Faculdade de Medicina, Universidade de São Paulo, SP - Brazil. viviane.hotta@fleury.com.br

Arquivos Brasileiros De Cardiologia
|July 27, 2011
PubMed
Summary

Cardiac resynchronization therapy (CRT) helps severe heart failure patients, but some don't improve. Three-dimensional echocardiography may identify patients who benefit most from CRT, including those with hyperresponsiveness.

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Related Experiment Videos

Last Updated: May 30, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

Area of Science:

  • Cardiology
  • Medical Imaging
  • Heart Failure Management

Background:

  • Cardiac resynchronization therapy (CRT) is a key treatment for severe heart failure.
  • A significant portion of patients (around 30%) do not respond positively to CRT.
  • Patient selection for CRT remains a challenge.

Observation:

  • A subset of patients (approximately 10%) exhibit hyperresponsiveness to CRT.
  • Identifying these patients is crucial for optimizing treatment outcomes.
  • Three-dimensional echocardiography offers advanced visualization capabilities.

Findings:

  • Three-dimensional echocardiography can be a valuable tool for patient selection in CRT.
  • This imaging modality may help evaluate patient response, including hyperresponsiveness.
  • Improved patient selection can lead to better CRT efficacy.

Implications:

  • Utilizing 3D echocardiography could enhance the success rates of cardiac resynchronization therapy.
  • This approach may reduce treatment costs by avoiding ineffective procedures.
  • Personalized medicine in heart failure management can be advanced through advanced imaging techniques.